These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3554275)

  • 1. Clearance approaches in pharmacology.
    Wilkinson GR
    Pharmacol Rev; 1987 Mar; 39(1):1-47. PubMed ID: 3554275
    [No Abstract]   [Full Text] [Related]  

  • 2. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm.
    Boxenbaum H
    Drug Metab Rev; 1984; 15(5-6):1071-121. PubMed ID: 6396053
    [No Abstract]   [Full Text] [Related]  

  • 3. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical pharmacokinetics as part of clinical pharmacology.
    Gladtke E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):37-41. PubMed ID: 4924326
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy: drug disposition in old age.
    Greenblatt DJ; Sellers EM; Shader RI
    N Engl J Med; 1982 May; 306(18):1081-8. PubMed ID: 7040951
    [No Abstract]   [Full Text] [Related]  

  • 6. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of liver disease on drug pharmacokinetics].
    Su CY
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative structure-pharmacokinetics relationships and their importance in drug design, possibilities and limitations.
    Seydel JK
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):571-81. PubMed ID: 6513673
    [No Abstract]   [Full Text] [Related]  

  • 9. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 10. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic circulation and drug disposition in cirrhosis.
    Shand DG
    Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
    [No Abstract]   [Full Text] [Related]  

  • 12. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug administration in hepatic disease.
    Williams RL
    N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fixation of drugs on plasma proteins].
    Tillement JP; Houin G; Zini R; Urien S; Albengres E; Barré J; Sébille B
    Sem Hop; 1983 May; 59(18):1413-22. PubMed ID: 6306828
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of haemodynamic alterations on drug disposition. Haemodynamic drug interactions.
    Nies AS
    Neth J Med; 1977; 20(2):46-58. PubMed ID: 325425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of plasma and tissue protein binding on the apparent volume of distribution of drugs].
    Houin G; Barre J; Tillement JP
    Therapie; 1984; 39(3):247-51. PubMed ID: 6463952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.